Tilray to report earnings
Tilray (TLRY) is scheduled to report its fourth-quarter earnings on March 18 after the market closes. So far, the company has had a weak performance this year compared to its peers. Tilray has returned ~2% YTD (year-to-date) compared to its peers (HMMJ). Aphria (APHA) has risen 56%. Aurora Cannabis (ACB) has returned ~50%, while and Cronos Group (CRON) has returned nearly 85% YTD.
Analysts expect Tilray’s sales to grow ~26% sequentially to $12.6 million in the fourth quarter from $10 million. The company reported sequential growth of ~3% in the previous quarter.